Literature DB >> 14755030

Black Caribbean adults with HIV in England, Wales, and Northern Ireland: an emerging epidemic?

S Dougan1, L J C Payne, A E Brown, K A Fenton, L Logan, B G Evans, O N Gill.   

Abstract

BACKGROUND: HIV is now well established in the Caribbean, with prevalence in several countries being surpassed only by those of sub-Saharan Africa. Continuing inward migration from the Caribbean and a high incidence of some bacterial STIs among Britain's black Caribbean communities, suggests a considerable potential for HIV spread.
METHODS: Data from three national HIV/AIDS surveillance systems were reviewed, providing information on new HIV diagnoses, numbers accessing treatment and care services, and HIV prevalence.
RESULTS: Between 1997 and 2001, 528 black Caribbean adults were newly diagnosed with HIV; 62 new diagnoses in 1997, rising to 176 in 2001. Probable heterosexual acquisition accounted for 335 (63%) infections (161 (48%) males, 174 females), and sex between men 171 (32%). Infection was acquired both in the Caribbean and in the United Kingdom. Numbers of black Caribbeans accessing treatment and care services more than doubled between 1997 (294) and 2001 (691). In 2001, 528 (76%) black Caribbeans accessing services were London residents. Among the Caribbean born previously undiagnosed heterosexuals, HIV prevalence was 0.7%; among men who have sex with men (MSM) it was 10.4%. Of those born in the Caribbean, 73% of male heterosexuals, 50% of female heterosexuals, and 65% of MSM who were previously undiagnosed left the clinic unaware of their HIV infection.
CONCLUSIONS: Numbers of black Caribbean adults newly diagnosed and accessing treatment and care services in England, Wales, and Northern Ireland increased between 1997 and 2001. Despite a high prevalence of diagnosed bacterial STIs, prevalence among Caribbean born heterosexuals remains low, but it is high among MSM. Surveillance data highlight the need for targeted HIV prevention among black Caribbeans.

Entities:  

Mesh:

Year:  2004        PMID: 14755030      PMCID: PMC1758387          DOI: 10.1136/sti.2003.006163

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  13 in total

1.  Comparison of risk factors for four sexually transmitted infections: results from a study of attenders at three genitourinary medicine clinics in England.

Authors:  G Hughes; M Catchpole; P A Rogers; A R Brady; G Kinghorn; D Mercey; N Thin
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  Demographic and behavioural profile of adults infected with chlamydia: a case-control study.

Authors:  K W Radcliffe; S Ahmad; G Gilleran; J D Ross
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 3.  Strategies for improving sexual health in ethnic minorities.

Authors:  K A Fenton
Journal:  Curr Opin Infect Dis       Date:  2001-02       Impact factor: 4.915

4.  Geomapping of chlamydia and gonorrhoea in Birmingham.

Authors:  M Shahmanesh; S Gayed; M Ashcroft; R Smith; R Roopnarainsingh; J Dunn; J Ross
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

5.  Assortative sexual mixing in a heterosexual clinic population--a limiting factor in HIV spread?

Authors:  D Barlow; G Daker-White; B Band
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

6.  Inequalities in rates of gonorrhoea and chlamydia between black ethnic groups in south east London: cross sectional study.

Authors:  N Low; J A Sterne; D Barlow
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

Review 7.  A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?

Authors:  J A Røttingen; D W Cameron; G P Garnett
Journal:  Sex Transm Dis       Date:  2001-10       Impact factor: 2.830

Review 8.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Authors:  D T Fleming; J N Wasserheit
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

9.  Sexual behaviour and sexually transmitted infection among African and Caribbean men in London.

Authors:  B A Evans; R A Bond; K D MacRae
Journal:  Int J STD AIDS       Date:  1999-11       Impact factor: 1.359

10.  National assessment of prevalent diagnosed HIV infections.

Authors:  A McHenry; N Macdonald; K Sinka; J Mortimer; B Evans
Journal:  Commun Dis Public Health       Date:  2000-12
View more
  5 in total

1.  HIV, sexual risk, and ethnicity among men in England who have sex with men.

Authors:  F Hickson; D Reid; P Weatherburn; M Stephens; W Nutland; P Boakye
Journal:  Sex Transm Infect       Date:  2004-12       Impact factor: 3.519

2.  The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London.

Authors:  M Ramaswamy; C McDonald; C Sabin; M Tenant-Flowers; M Smith; A M Geretti
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

3.  Sexual health of ethnic minority MSM in Britain (MESH project): design and methods.

Authors:  Jonathan Elford; Eamonn McKeown; Rita Doerner; Simon Nelson; Nicola Low; Jane Anderson
Journal:  BMC Public Health       Date:  2010-07-14       Impact factor: 3.295

4.  Second Generation of HIV Surveillance System: A Pattern for Iran.

Authors:  M Nematollahi; N Khalesi; H Moghaddasi; M Askarian
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

Review 5.  A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy.

Authors:  Ibidun Fakoya; Débora Álvarez-del Arco; Melvina Woode-Owusu; Susana Monge; Yaiza Rivero-Montesdeoca; Valerie Delpech; Brian Rice; Teymur Noori; Anastasia Pharris; Andrew J Amato-Gauci; Julia del Amo; Fiona M Burns
Journal:  BMC Public Health       Date:  2015-06-19       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.